Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | ENPP3 | O14638 | 2/20 | 0.43 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.43 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6198029 | 1.00 | CYP2D6 (0.63) | CYP2D6CYP1A2ACHEKMT2ASMN1; SMN2 | |
| SCHEMBL6198035 | 1.00 | CYP2D6 (0.63) | CYP2D6CYP1A2ACHEKMT2ASMN1; SMN2 | |
| Fluoride SCHEMBL27871310 | 0.98 | CYP2D6 (0.61) | CYP2D6CYP1A2ACHEKMT2ASMN1; SMN2 | |
| SCHEMBL777214 | 0.96 | CYP2D6 (0.63) | CYP2D6CYP1A2ACHEKMT2ASMN1; SMN2 | |
| SCHEMBL23192021 | 0.95 | CYP2D6 (0.61) | CYP2D6CYP1A2ACHEKMT2ASMN1; SMN2 | |
| SCHEMBL8367865 | 0.95 | CYP2D6 (0.61) | CYP2D6CYP1A2ACHEKMT2ASMN1; SMN2 | |
| SCHEMBL11107669 | 0.95 | CYP2D6 (0.61) | CYP2D6CYP1A2ACHEKMT2ASMN1; SMN2 | |
| SCHEMBL8370244 | 0.95 | CYP2D6 (0.61) | CYP2D6CYP1A2ACHEKMT2ASMN1; SMN2 | |
| SCHEMBL22621292 | 0.95 | CYP2D6 (0.61) | CYP2D6CYP1A2ACHEKMT2ASMN1; SMN2 | |
| SCHEMBL24250706 | 0.95 | CYP2D6 (0.61) | CYP2D6CYP1A2ACHEKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070048-A1 | NITROGEN-CONTAINING BRANCHED POLYMER, ANION EXCHANGE MEMBRANE, AND METHOD FOR PREPARING ANION EXCHANGE RESIN | EVE HYDROGEN ENERGY CO LTD (CN) | 2026-03-12 | — | — | US | claimed |
| US-20250243320-A1 | SULFONATE GROUP-BASED ANION RESIN, PREPARATION METHOD THEREOF, AND ANION EXCHANGE MEMBRANE | EVE Hydrogen Energy Co., LTD. (CN) | 2025-07-31 | — | — | US | claimed |
| US-20250243308-A1 | NITROGEN-CONTAINING MULTICOMPONENT COPOLYMER, MANUFACTURING METHOD THEREOF, ANIONIC RESIN, AND ANION EXCHANGE MEMBRANE | EVE Hydrogen Energy Co., LTD. (CN) | 2025-07-31 | — | — | US | claimed |
| EP-4591978-A1 | SULFONATE GROUP-BASED ANION RESIN, PREPARATION METHOD THEREOF, AND ANION EXCHANGE MEMBRANE | EVE Hydrogen Energy Co., LTD. (CN) | 2025-07-30 | — | — | EP | claimed |
| EP-4591970-A1 | NITROGEN-CONTAINING MULTICOMPONENT COPOLYMER, MANUFACTURING METHOD THEREOF, ANIONIC RESIN, AND ANION EXCHANGE MEMBRANE | EVE Hydrogen Energy Co., LTD. (CN) | 2025-07-30 | — | — | EP | claimed |
| CN-119264352-A | Nitrogen-containing branched polymer, anion exchange resin, anion exchange membrane and electrochemical device | 惠州亿纬氢能有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-118027359-A | Nitrogen-containing compound, preparation method thereof, anion resin and anion exchange membrane | 惠州亿纬氢能有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-117924629-A | Nitrogen-containing multipolymer, preparation method thereof, anion resin and anion exchange membrane | 惠州亿纬氢能有限公司 | 2024-04-26 | — | — | CN | claimed |
| WO-2026087442-A1 | AMINO-IMIDAZOLE ANTIBACTERIAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2026-04-30 | — | — | WO | disclosed |
| US-20260070048-A1 | NITROGEN-CONTAINING BRANCHED POLYMER, ANION EXCHANGE MEMBRANE, AND METHOD FOR PREPARING ANION EXCHANGE RESIN | EVE HYDROGEN ENERGY CO LTD (CN) | 2026-03-12 | — | — | US | disclosed |
| US-20250243308-A1 | NITROGEN-CONTAINING MULTICOMPONENT COPOLYMER, MANUFACTURING METHOD THEREOF, ANIONIC RESIN, AND ANION EXCHANGE MEMBRANE | EVE Hydrogen Energy Co., LTD. (CN) | 2025-07-31 | — | — | US | disclosed |
| US-20250243309-A1 | NITROGEN-CONTAINING COMPOUNDS AND PREPARATION METHOD THEREOF, ANIONIC RESIN, AND ANIONIC EXCHANGE MEMBRANE | EVE Hydrogen Energy Co., LTD. (CN) | 2025-07-31 | — | — | US | disclosed |
| US-20250243320-A1 | SULFONATE GROUP-BASED ANION RESIN, PREPARATION METHOD THEREOF, AND ANION EXCHANGE MEMBRANE | EVE Hydrogen Energy Co., LTD. (CN) | 2025-07-31 | — | — | US | disclosed |
| EP-4592330-A1 | NITROGEN-CONTAINING COMPOUNDS AND PREPARATION METHOD THEREOF, ANIONIC RESIN, AND ANIONIC EXCHANGE MEMBRANE | EVE Hydrogen Energy Co., LTD. (CN) | 2025-07-30 | — | — | EP | disclosed |
| EP-1117669-B1 | ANTIVIRAL PURINE DERIVATIVES | UNIV CARDIFF (GB) | 2003-01-29 | — | — | EP | disclosed |
| US-20010031745-A1 | Antiviral purine derivatives | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2001-10-18 | — | — | US | disclosed |
| EP-1117669-A1 | ANTIVIRAL PURINE DERIVATIVES | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LTD. (GB) | 2001-07-25 | — | — | EP | disclosed |
| WO-2000018775-A1 | ANTIVIRAL PURINE DERIVATIVES | UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) | 2000-04-06 | — | — | WO | disclosed |
| EP-0970132-A1 | CATALYTICALLY ACCELERATED GASEOUS PHASE REACTIONS | Chen, Peter (CH) | 2000-01-12 | — | — | EP | disclosed |
| WO-1999037692-A1 | CATALYTICALLY ACCELERATED GASEOUS PHASE REACTIONS | CHEN PETER (CH) | 1999-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070048-A1 | NITROGEN-CONTAINING BRANCHED POLYMER, ANION EXCHANGE MEMBRANE, AND METHOD FOR PREPARING ANION EXCHANGE RESIN | SLC9A2, SLC9A3, SLC9B2 | CYP2D6 3083/4885CYP1A2 3421/4885ACHE 4670/4885 |
| US-20010031745-A1 | Antiviral purine derivatives | PNP, TYMP, MTAP | CYP2D6 1659/4885CYP1A2 3072/4885ACHE 2799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.